# Postpartum NSAIDS and Maternal Hypertension

Study · id `cardio:ct-nct03824119` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03824119](<https://clinicaltrials.gov/study/NCT03824119>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03824119

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT03824119. Randomized; no masking; primary purpose treatment. Start 2018-12-11 (actual); primary completion 2022-12-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT03824119, source copy `cardio:ctgov-nct03824119-2020-11-06`, retrieved 2026-10-26)
- Started: 2018-12-11 (actual) (ClinicalTrials.gov record NCT03824119, source copy `cardio:ctgov-nct03824119-2020-11-06`, retrieved 2026-10-26)
- Primary completion: 2022-12-11 (anticipated) (ClinicalTrials.gov record NCT03824119, source copy `cardio:ctgov-nct03824119-2020-11-06`, retrieved 2026-10-26)
- Completion: 2022-12-11 (anticipated) (ClinicalTrials.gov record NCT03824119, source copy `cardio:ctgov-nct03824119-2020-11-06`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03824119, source copy `cardio:ctgov-nct03824119-2020-11-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03824119-2020-11-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Postpartum NSAIDS and Maternal Hypertension
- Condition: Preeclampsia
- Condition: Gestational Hypertension
- Condition: Superimposed Preeclampsia
- Condition: Chronic Hypertension in Obstetric Context
- Intervention (Drug): Ibuprofen 600 mg
- Intervention (Other): Standard Postpartum Care without NSAIDs
- Lead sponsor: University of Southern California
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University of Southern California (`cardio:org-university-of-southern-california`)

## Provenance

Content hash: cf1069ca68617865f159339e320ecb4a1647313b835efa344e77a114bf2965dc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
